“Real-world” effectiveness of daily controller medicine in children with mild persistent asthma
Don A. Bukstein(Institute for Asthma and Allergy), Avi J. Bernstein(Dean Health Systems), Allan T. Luskin(Dean Health Systems)
Cited by 71
Related Papers
The economic impact of allergic rhinitis and current guidelines for treatment
|Annals of Allergy Asthma & Immunology|2011|268
Shared decision making for the allergist
|Annals of Allergy Asthma & Immunology|2018|119
The Challenges and Opportunities for Shared Decision Making Highlighted by COVID-19
|The Journal of Allergy and Clinical Immunology In Practice|2020|119
Digital Health Technology in Asthma: A Comprehensive Scoping Review
|The Journal of Allergy and Clinical Immunology In Practice|2021|119
Evaluation of a short form for measuring health-related quality of life among pediatric asthma patients
|Journal of Allergy and Clinical Immunology|2000|93